Spotlight: Advance Biotech Grant Program

Unlock your molecule’s potential. Apply to the US and Canada Advance Biotech Grant Program Your promising molecule requires resources and support to realize it’s potential. Our Advance Biotech Grant Program, 6th edition, is open to biotech start-up companies in US and Canada to help you accelerate to clinic faster. Apply now for a chance to win [...]

February 1st, 2019|

Spotlight: Biotech Companies in the “Big 3” Regions Rake in the Cash

  BioWeekSF will soon be here again — January 5-10, 2019 — the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation, the week’s premium online guide,, is showcasing a series of reports and other resources focusing on financing and dealmaking. This feature is from DealForma, the biopharma database providing you [...]

November 13th, 2018|

Spotlight: What Small and Emerging Companies Need When Entering Into Dealmaking Discussions

BioWeekSF will soon be here again -- January 6-11, 2019 -- the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation,  the week's premium online guide,, is sponsoring a series of viewpoints and more from leaders and professionals involved in life sciences/healthcare dealmaking. As Chair of Foley Hoag's Licensing & [...]

October 14th, 2018|

Many Hospitals Don’t Restrict Drug Industry Payments to Doctors

 Intro of feature from KPBS about drug industry payments to doctors at San Diego-area hospitals: "Drug and device company payments to physicians may influence prescribing practices and treatment recommendations that may not be in the best interests of patients, especially when cheaper equivalents are available. Doctors have accepted free meals, gifts, travel expenses and other [...]

June 30th, 2016|

How Jay Flatley Created A Market For DNA Sequencing From Scratch

A brief feature from Business Insider on Illumina and Jay Flatley - an excerpt: "Illumina might not necessarily be a company with a household name, but it has an immense presence within the life sciences industry. And Jay Flatley, the company's outgoing CEO, is the man who made it all happen. Flatley essentially created a market [...]

June 20th, 2016|

NuVasive Buys Biotronic for $98M

From Amirah Al Idrus/FierceMedicalDevices: "Spine specialist NuVasive ($NUVA) bolstered its product lineup when it acquired Ellipse in January. Now, the San Diego-based company is looking toward increasing its value-based healthcare offerings with the $98 million acquisition of Biotronic NeuroNetwork, which monitors patients' nervous systems during surgery. Biotronic provides real-time, remote monitoring of patients' neurophysiology to [...]

June 7th, 2016|

Skaggs Family Donates $2 Million to Scripps Research

From press release: "The Skaggs family has given a new $2 million gift to support exceptional students in The Scripps Research Institute (TSRI) graduate program. "I would like to thank members of the Skaggs family for their remarkable generosity, which has had a transformative effect on this institution," said TSRI CEO Peter Schultz. "This new [...]

June 2nd, 2016|

An Unknown Billionaire’s Big Bet on Beating Aging

Forbes has a great profile feature by Matthew Herper on Osman Kibar and his company Samumed - an excerpt: "Kibar, an engineering Ph.D. who emigrated from Turkey to the U.S. for college, doesn’t need to bet on cards for money. Samumed, the San Diego firm he has been stealthily building for a decade, is the most [...]

April 13th, 2016|

Human Longevity Raises More Than $220 Million

The intro of Human Longevity's press release on their raising of more than $220 million from Series A investors and pharma companies: "Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that the company has completed an offering of Series B Preferred Stock, raising in excess of $220 million. HLI previously raised $80 million in [...]

April 5th, 2016|

UCSD Work Attracts Paul Allen’s Millions

Excerpt from Alex Lash's Xconomy article about Paul Allen's new $100M biotech research initiative: "Whether those headline-grabbing scenarios come true, or CRISPR-Cas9 just remains a useful tool for all kinds of biological research, one thing is for sure. CRISPR-Cas9 does what it does by cutting DNA. But in a paper published last week in Cell, [...]

March 24th, 2016|

Orexigen Acquires All US Rights to Contrave

Terms of the Orexigen-Takeda transaction (from press release) "The transaction is expected to close in late March 2016 following receipt of clearance under the HSR Act. At the closing, Orexigen will pay Takeda $60 million to acquire Contrave U.S. rights. Following completion of the transition period, Orexigen is required to pay Takeda an additional $15 [...]

March 15th, 2016|

Seeking a Best-in-Class Antibody at Bargain Basement Prices

From caption from The Bio Report: "Bird Rock Bio, a small, San Diego-based biotech, is planning to take aim at some of the biggest biologics on the market with an antibody in development to treat rheumatoid arthritis that it says it expects to market at an annual cost of just $2,000 a year. [...]

March 3rd, 2016|

The Long, Rocky Road for Young Biotechs

In one of the best in-depth features about executives seeking funding and more during the JP Morgan Healthcare Conference week, Lisa M. Jarvis (for Chemical & Engineering News) writes a cover story, "The Long, Rocky Road From Idea To Successful Biotech," about Zak Zimmerman and David Puerta of Forge Therapeutics (San Diego) and their days and nights in San [...]

February 22nd, 2016|

CIRM Plots Its Future

  From Daniel Levine/The Bio Report: "The California Institute for Regenerative Medicine, California’s voter-established stem cell agency, is thinking about its future. The institute recently issued a strategic plan for the next five years that it says represents a “radical overhaul of the way the institute conducts business” and emphasizes “coordination, speed, partnerships, [...]

February 19th, 2016|

Tax Policies Can Hurt California’s Growth in Life Sciences

From CLSA President Sara Radcliffe in a special commentary for the San Diego Union-Tribune (intro): "For generations, California has led the way in advancing innovations that drive the economy and create jobs. That is certainly the case with the life sciences — biotechnology, pharmaceuticals, medical devices and diagnostics — a sector that helps fuel economic [...]

February 5th, 2016|

San Diego-Area Biotechs Dominate “Startups to Watch” List

From Biospace: "BioSpace (DHX) is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States. Once BioSpace sorted the companies into that group, they were then weighted by a number of different categories and ranked in [...]

January 26th, 2016|

Startups Rake in Venture Capital

Excerpt of article from Mike Freeman for the San Diego Union Tribune: “There were a couple of mega-deals in the last six months, two large deals that accounted for $241 million,” said Ryan Spencer of PricewaterhouseCoopers in San Diego. “But even if I remove those two deals, this was still the best six-month window since mid-2012.” [...]

January 15th, 2016|

NuVasive Buys Ellipse for $380M

Excerpts of coverage: "NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, and Ellipse Technologies, Inc. (“Ellipse”), a privately held medical technology company focused on revolutionizing procedural solutions for complex skeletal deformity, today announced that the Boards of Directors of both companies have unanimously approved [...]

January 6th, 2016|

UC Commits $250M For A New Tech Venture Fund For Biotech, More

From FierceBiotech: "The University of California is committing $250 million to back a venture fund that will be led by Silicon Valley entrepreneur Vivek Ranadivé, who will take the lead on investing in a slate of university spinouts involved in biotech and more. UC's Board of Regents says that they decided to go with a [...]

December 17th, 2015|